# TB-Vision Pro: An Intelligent Tuberculosis Diagnosis System Based on Multimodal Deep Learning

> A consensus architecture medical diagnosis platform integrating Vision Transformer, ResNet-50, and MobileNetV2, combined with MedSAM segmentation technology and clinical data analysis, enabling early screening of tuberculosis, lesion visualization, and rehabilitation tracking.

- 板块: [Openclaw Llm](https://www.zingnex.cn/en/forum/board/openclaw-llm)
- 发布时间: 2026-04-23T04:17:54.000Z
- 最近活动: 2026-04-23T04:47:41.477Z
- 热度: 154.5
- 关键词: 肺结核检测, 医疗AI, 深度学习, Vision Transformer, ResNet, MobileNet, MedSAM, 医学影像, 多模态融合, 开源医疗
- 页面链接: https://www.zingnex.cn/en/forum/thread/tb-vision-pro
- Canonical: https://www.zingnex.cn/forum/thread/tb-vision-pro
- Markdown 来源: floors_fallback

---

## TB-Vision Pro: Multimodal Deep Learning Empowers Intelligent Tuberculosis Diagnosis

TB-Vision Pro is an open-source medical diagnosis platform with a consensus architecture integrating Vision Transformer, ResNet-50, and MobileNetV2. Combined with MedSAM segmentation technology and clinical data analysis, it enables early screening of tuberculosis, lesion visualization, and rehabilitation tracking, providing an innovative solution to the time-consuming and subjective misdiagnosis issues in traditional diagnostic processes.

## Current Status and Challenges of Tuberculosis Diagnosis

As a major global public health challenge, tuberculosis causes millions of infections each year. Early detection and accurate diagnosis are key to controlling the epidemic. Traditional diagnosis relies on doctors' experience and tedious image analysis, which is time-consuming and prone to misdiagnosis due to subjective factors.

## Three-Model Consensus Decision System: Core Competitiveness

TB-Vision Pro adopts a consensus architecture with parallel analysis of three models:
- **Vision Transformer (ViT)**：Captures the global structure and long-range dependencies of lung images, excels at identifying diffuse lesions;
- **ResNet-50**：Extracts multi-scale texture features via residual networks, accurately identifies typical pathological manifestations such as nodules and cavities;
- **MobileNetV2**：Achieves fast inference with depthwise separable convolution, suitable for resource-constrained environments.
The final results are integrated via a weighted fusion algorithm to reduce the bias of a single model and improve robustness.

## MedSAM Segmentation: Transparency and Efficiency Optimization of AI Diagnosis

The system integrates MedSAM segmentation technology, automatically annotates affected lung areas and generates color-coded severity maps, enabling visual interpretation of diagnostic results and enhancing doctors' trust. It also supports image upload via Ctrl+V paste, simplifying the operation process and improving work efficiency.

## Longitudinal Tracking: From Single Screening to Full-Cycle Management

The platform has a built-in longitudinal analysis function that can automatically identify follow-up patients and generate rehabilitation progress charts, showing the trend of TB risk probability changes, which helps evaluate treatment effects and adjust plans. This design realizes the transition from a diagnostic tool to a comprehensive management platform.

## Technology Stack and Data Insight Support

**Technology Stack**: Frontend built with React18+Vite+TailwindCSS, backend using FastAPI asynchronous framework, AI layer integrating TensorFlow/Keras ecosystem;
**Data Insight**: Real-time dashboard provides screening speed monitoring, patient demographic analysis, and recent activity streams, offering data support for medical institution management and public health decision-making.

## Clinical Significance and Future Outlook

TB-Vision Pro represents the evolution direction of AI medical diagnosis from a single function to a comprehensive platform, providing end-to-end prevention and control support. The project states that it is only for research and clinical demonstration; actual diagnosis requires the participation of professional medical personnel. In the future, through the maturity of MedSAM technology, multi-center validation, and data accumulation, it will help tuberculosis prevention and control in resource-poor areas and promote the achievement of global elimination goals.